Cargando…
Modulation of alternative splicing induced by paclitaxel in human lung cancer
Paclitaxel is utilized as the first-line chemotherapeutic regimen for the majority of advanced non-small-cell lung carcinoma. However, whether paclitaxel could suppress cancer progression through modulating RNA alternative splicing remains largely unknown. Here, we demonstrated the effects of paclit...
Autores principales: | Zhu, Ziran, Chen, Dan, Zhang, Wenjing, Zhao, Jinyao, Zhi, Lili, Huang, Fang, Ji, Haoyu, Zhang, Jinrui, Liu, Han, Zou, Lijuan, Wang, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5924756/ https://www.ncbi.nlm.nih.gov/pubmed/29706628 http://dx.doi.org/10.1038/s41419-018-0539-4 |
Ejemplares similares
-
Aberrant alternative splicing in breast cancer
por: Yang, Quan, et al.
Publicado: (2019) -
Melatonin inhibits HCC progression through regulating the alternative splicing of NEMO
por: Bai, Lu, et al.
Publicado: (2022) -
SRSF1 inhibits autophagy through regulating Bcl-x splicing and interacting with PIK3C3 in lung cancer
por: Lv, Yuesheng, et al.
Publicado: (2021) -
SRSF1 modulates PTPMT1 alternative splicing to regulate lung cancer cell radioresistance
por: Sheng, Junxiu, et al.
Publicado: (2018) -
Pharmacology of Modulators of Alternative Splicing
por: Bates, David O., et al.
Publicado: (2017)